In the developing mouse retina, multipotent retinal progenitor cells (RPCs) give rise to specific retinal cell types at different times, but the molecular mechanisms regulating how RPCs change over time remain unclear. In the Drosophila neuroblast lineage, the zinc finger transcription factor Hunchback (Hb) is both necessary and sufficient to specify earlyborn neuronal identity. We show here that Ikaros, a mouse ortholog of Hb, is expressed in all early embryonic RPCs, which then give rise to Ikaros-negative RPCs at later stages in the lineage. Remarkably, misexpression of Ikaros in late RPCs is sufficient to confer competence to generate early-born neurons. Conversely, Ikaros mutant mice have reduced numbers of early-born cell types, whereas late-born cell types are not affected. These results suggest a model in which Ikaros expression is both necessary and sufficient to confer early temporal competence to RPCs and raise the possibility that a similar strategy might be used to control the sequential order of cell birth in other parts of the nervous system.
INTRODUCTION
During development of the nervous system, neural progenitor cells give rise to different cell types at specific times. The precise control of the chronological order of cell birth is critical in the formation of a fully functional nervous system. Although considerable progress has been made recently in identifying genes involved in the specification of particular cell types, the mechanisms that control how neural progenitor cells change over time to generate the right cell type at the right time remain poorly understood. Elucidating these mechanisms operating during normal development may have important implications for therapeutic uses of neural stem cells.
The mouse retina provides an ideal system to study the problem of temporal regulation of cell birth because multipotent retinal progenitor cells (RPCs) give rise to different retinal cell types in a reproducible order during development (reviewed in Livesey and Cepko, 2001) . At early embryonic stages, retinal ganglion cells, horizontal cells, and cone photoreceptors are produced.
Then, at midembryonic stages of development, most amacrine cells are generated. Finally, in the late stages of retinal development, the majority of rod photoreceptors, bipolar cells, and Mü ller glial cells are produced (Rapaport et al., 2004; Young, 1985) . What are the molecular mechanisms that operate in RPCs to ensure that the correct cell type is produced on schedule? There is now strong evidence that RPCs gain and loose the ''competence'' to generate a particular combination of cell types as they mature over time (Cepko et al., 1996; Livesey and Cepko, 2001; Watanabe and Raff, 1992) . Although negative feedback environmental signals can apparently influence RPC fate decisions and the timing of retinogenesis (reviewed in Cayouette et al., 2006) , recent experiments highlight the importance of cell intrinsic mechanisms in retinal cell-fate decisions (Cayouette et al., 2003; Kay et al., 2005; Mu et al., 2005b; Poggi et al., 2005) . Similarly, experiments with cortical progenitors have shown that the timing of neurogenesis is programmed within individual progenitor cells and depends mainly on cell-intrinsic mechanisms (Hanashima et al., 2004; Shen et al., 2006) . However, the identity of cell intrinsic factors that actually define a particular competence state during vertebrate neural development remains largely unknown. As RPC competence changes over time, we shall call these ''temporal competence'' factors.
In Drosophila, cell-intrinsic temporal competence factors in neural progenitor cells have recently been identified in a series of elegant experiments in the embryonic neuroblast lineage (Grosskortenhaus et al., 2005 (Grosskortenhaus et al., , 2006 Isshiki et al., 2001; Pearson and Doe, 2003) and in postembryonic development of the brain (Zhu et al., 2006) . In the embryo, it was shown that each neuroblast expresses sequentially, in an invariant order, four transcription factors called hunchback, Kru¨ppel, pdm, and castor (Brody and Odenwald, 2000; Isshiki et al., 2001; Kambadur et al., 1998; Novotny et al., 2002; Pearson and Doe, 2003) . The relevance of these temporal competence factors to neuronal fate was addressed using gain-of-function and loss-of-function approaches, resulting in respecification of the neuroblast progeny to earlier or later fates (Grosskortenhaus et al., 2006; Isshiki et al., 2001; Pearson and Doe, 2003) .
Could similar molecular machinery exist in the developing vertebrate nervous system and, more specifically, in the retina to define RPC temporal competence so that appropriate retinal cell types are generated at the right time? Hunchback orthologs in vertebrates constitute a Krü ppel zinc finger family of transcription factors that includes the founding member ikaros, as well as aiolos, helios, eos, and the more distant member pegasus. These genes are characterized by N-terminal zinc finger DNA-binding domains and C-terminal zinc fingers related to the Drosophila protein Hunchback ( Figure 1A ; Cobb and Smale, 2005; Cortes et al., 1999) . The C terminus contains a dimerization domain required for the formation of homo-and heterodimers, which are thought to play an important part in the regulation of the overall activity of the different family members (Cobb et al., 2000; Kelley et al., 1998; Morgan et al., 1997; Perdomo et al., 2000; Sun et al., 1996) . The role of Ikaros has been most studied in the hematopoietic system, where it is thought to function as a key factor for differentiation at a number of branch points in the hematopoietic lineage (Georgopoulos, 2002) . In contrast, the role of Ikaros in the nervous system is still unclear, but recent evidence indicates that it plays a part in some aspects of neural development (Agoston et al., 2007; Ezzat et al., 2006) . It remains unknown, however, whether Ikaros is involved in retinal development and in the regulation of temporal competence.
We report here that Ikaros is expressed in early, but not late, RPCs and in early-born retinal neurons. Misexpression of Ikaros in late postnatal RPCs is sufficient to induce the generation of early-born cell types such as retinal ganglion cells (RGCs), horizontal cells, and amacrine cells, which are normally either not generated, or rarely generated at this age. Importantly, mouse mutants of Ikaros show decreased generation of earlyborn neurons, whereas generation of late-born cell types is not affected.
RESULTS

Ikaros Is Expressed in Early Progenitors and Early-Born Neurons
To examine the potential role of Ikaros in RPC temporal competence, we first defined its expression pattern during retinal development. We found that ikaros mRNA was weakly but consistently expressed in all retinal layers of the developing retina from early embryonic to late postnatal stages ( Figures 1B-1F ). Since the in situ signal was weak and did not appear to change over time, we next wanted to confirm the presence of ikaros (B-E) In situ hybridization on mouse retinal sections from E13 to P5 using an antisense riboprobe designed against Ikaros. Inset shows high magnification of the boxed region. Note the specific perinuclear signal in the progenitor cell layer (PRL), as well as in cells located in the inner nuclear layer (INL), ganglion cell layer (GCL), and outer nuclear layer (ONL) at P5. (F) A control probe against the transcription factor Crx shows the expected signal in photoreceptors, but no signal is observed in other retinal layers. Both Ikaros and Crx in situs were processed together and developed for the same time.
(G) qRT-PCR for Ikaros on the 4N DNA content cell population (RPCs) isolated from E14 or P0 mouse retina. No difference in the levels of Ikaros mRNA was observed between E14 and P0 RPCs. (H) Western blot of total protein extracts from P1 mouse retina using the 4E9 anti Ikaros antibody. A single band of the expected size for the Ikaros-1 isoform is detected. Total protein extract from P0 mouse thymus is used as positive control, showing different Ikaros isoforms (Ik-1, Ik-2, and Ik-3). (I-L) Immunostaining with a monoclonal Ikaros antibody on rat retinal sections at different stages of development, as indicated. Ikaros (red) is expressed in all RPCs at E11 in the neural retina (boxed area), and also in presumptive retinal pigment epithelium and lens. At later stages, Ikaros expression is limited to a subpopulation of RPCs in the progenitor layer (PRL), and in some postmitotic cells located in the inner nuclear layer (INL). By P2, a few rare Ikaros-positive cells (arrows) are still detected in the PRL (boxed area is magnified in lower left corner). The sections were counterstained with Hoechst (blue). (M-O) High magnification of a P2 retinal section stained for Ikaros (green) and proliferating cell nuclear antigen (PCNA, red). At this stage, a few Ikaros-positive RPCs are still detected, as seen by costaining with PCNA (arrowheads), but the majority of PCNA-positive RPCs do not express Ikaros.
mRNA in RPCs and quantify the level of expression at early and late stages of retinogenesis. To do this, we dissociated mouse retinas at E13 and P0 and stained the cell suspension with the cell -permeable DNA dye Hoechst. We then used fluorescence activated cell sorting (FACS) to purify cells with 4N DNA content, which represent a fraction of the RPC population (Livesey et al., 2004) . We then quantified ikaros mRNA levels using quantitative RT-PCR (qRT-PCR). As expected from the in situ results, we found that Ikaros was expressed in RPCs, but the level of expression did not change significantly between E13 and P0 ( Figure 1G ). These results indicate that ikaros mRNA is expressed in RPCs but it is not temporally regulated.
We next wanted to determine whether Ikaros protein expression could change over time in RPCs. To do this, we used a previously characterized monoclonal antibody raised against Ikaros (clone 4E9; Kim et al., 1999) . Western blot of total protein extracts from P1 retina confirmed that this antibody recognize a single band at the expected molecular weight for the Ikaros-1 isoform, whereas multiple bands corresponding to the different Ikaros isoforms were detected in thymus protein extract, which was used as positive control ( Figure 1H ). To determine which cell types express Ikaros during retinogenesis, we stained rat retinal sections at different stages of development. At early embryonic stages, we found that virtually all RPCs stained for Ikaros, but the proportion of Ikaros-positive RPCs decreased progressively over time ( Figures 1I-1L ). At postnatal day 2 (P2), although there were still many proliferating cell nuclear antigen (PCNA)-positive RPCs, only a few rare RPCs were Ikaros-positive ( Figures 1M-1O ), and by P4 we could no longer detect any Ikaros-positive RPCs (not shown). At embryonic day (E) 17 and P2, Ikaros was also detected in the ganglion cell layer (GCL) and the inner nuclear layer (INL), which contain cell bodies of differentiated neurons. Similar results were obtained with a different anti-Ikaros polyclonal antibody (from S. Smale; not shown). These results indicate that Ikaros protein is expressed in early, but not late RPCs, consistent with a potential role of Ikaros in conferring early temporal competence. The Ikaros-positive and Ikaros-negative RPCs might be lineage related, or they might constitute two different pools of progenitors that expend at different stages of retinal development. To distinguish between these two possibilities, we infected retinal progenitors with a GFP-expressing retroviral vector at E13, a stage when virtually all RPCs express Ikaros, and fixed the retinas 5 days later, a stage when a large population of RPCs is Ikaros negative. The explants were then sectioned and stained for Ikaros and a RPC marker (Ki67). The clones were identified by GFP expression and analyzed for the presence of Ikaros and Ki67-positive cells. The prediction was that if Ikaros-positive RPCs actually give rise to Ikaros-negative RPCs at later stages in the lineage, we should find Ikaros-negative and Ikaros-positive RPCs within the same clone. As predicted, we found that some clones contained multiple RPCs and some were Ikaros positive whereas others were Ikaros negative (Figure 2 ). In these experiments, we also observed clones that contained Ikaros-positive postmitotic cells located in the GCL or INL, together with Ikaros-positive RPCs (not shown). Because only early-born cell types are generated at early stages, these results suggest that the Ikaros-positive neurons in the clones were generated from the Ikaros-positive progenitors. Taken together, these cell lineage tracing results show that Ikaros-positive RPCs generate Ikaros-negative RPCs within the same lineage, and suggest that Ikaros positivity is a temporal stage of most, if not all RPCs.
In the mature P12 retina, Ikaros-positive cells were detected in the INL and GCL. These Ikaros-positive cells expressed Pax6, a marker of horizontal, amacrine, and ganglion cells in the adult retina, suggesting Ikaros expression in these cells ( Figures 3A-3C ). To more precisely identify the Ikaros-positive cells in the mature retina, we stained with antibodies against specific markers of the different retinal cell types such as Lim-1 and Calbindin for horizontal cells, Pax6 and Calbindin for amacrine cells, and Brn3b for retinal ganglion cells (RGCs), and we found that all three cell types expressed Ikaros ( Figures 3A-3L ). In contrast, late-born bipolar cells, detected by PKCa expression, and Mü ller cells, detected by cyclin-D3 expression, did not stain for Ikaros ( Figures 3M-3R ). In addition, Ikaros-positive cells were never observed in the photoreceptor cell layer. In older, P60 adult rat retina, however, we did not find significant staining in earlyborn cell types anymore (not shown), suggesting that Ikaros protein expression is reduced below detectable levels over time. These results indicate that Ikaros protein expression is maintained, at least for some time, specifically in differentiated earlyborn cell types.
Inactivation of Ikaros Specifically Reduces the Generation of Early-Born Retinal Cell Types In Vivo
If Ikaros were involved in regulating early temporal competence, mouse mutants of ikaros should show an absence or decrease of early-born cell types, whereas late-born cell types should not be affected. To test this idea, we first analyzed the developing retina of ikaros knockout (ikaros À/À ) mice (Wang et al., 1996) , at differ- The reduced number of early-born cell types in the ikaros À/À embryonic retina could be explained by a specific increase in cell death in these cell populations. To test this possibility, we compared the number of TUNEL-positive cells in ikaros À/À and wild-type retinas at different stages of development. We did not find any increase in cell death in ikaros À/À retinas compared to wild-types at E13, E16, and P3 (see Figure S1 available online), suggesting that the reduced number of early-born cell types observed in the E13 and E16 ikaros À/À retinas is not caused by increased cell death. These results suggested that the reduced production of early-born cell types in ikaros À/À retinas might be due to decreased proliferation. To study the effect of Ikaros inactivation on cell proliferation, we stained retinal sections of ikaros À/À or wild-type littermates for phospho-histone H3 (PH3), a marker of mitotic cells, at different stages of retinal development. At E11, the number of PH3-positive cells was not different from wild-type littermates in ikaros À/À retinas ( Figure 5A ). At E13, however, we found a significant decrease in cell proliferation in ikaros À/À retinas compared to wild-type littermates ( Figures   5A-5C ). Interestingly, cell proliferation at E16 and P0 was no longer affected ( Figure 5A and not shown). These results suggest that inactivation of Ikaros causes a transient reduction in RPC proliferation, specifically in the early stages of retinogenesis when early-born cell types are being generated. The decrease in cells expressing markers of early-born cell types at E13 and E16 in the ikaros À/À retina could be due to a delay in their generation. If this were the case, the number of earlyborn cell types would be expected to have reached control values in the ikaros À/À adult retina. To test this hypothesis, we first analyzed histological sections of ikaros À/À adult retinas. We found that the INL and the GCL, which contain the cell bodies of the early-born cell types, were thinner and contained fewer cells than wild-types, whereas the thickness of the outer nuclear layer (ONL), which contains the cell bodies of photoreceptor cells, was not different and contained similar number of cells as wild-types ( Figures 6A-6E ). To more precisely determine whether early-born cell types are specifically decreased in the ikaros À/À adult retinas, we next stained for cell-type-specific Immunostaining on P12 rat retinal sections for Ikaros (left panels) and various cell-type-specific markers (middle panels) of early and late-born cell types as indicated. Right panels show a merged image. Ikaros is detected in the three cell types expressing Pax6 in the mature retina, the amacrine cells, horizontal cells, and ganglion cells (A-C). Ikaros expression also co-localizes with Lim-1 and Calbindin (D-I, arrowheads), two markers of horizontal cells, and with Brn3b, a marker of RGCs (J-L). However, Ikaros is not expressed in bipolar cells, which are stained for PKCa (M-O), and Mü ller cells, which are stained for CyclinD3 (P-R). For (P), the polyclonal anti-Ikaros antibody had to be used, which produce some nonspecific staining in the plexiform layers that is not seen with the mouse monoclonal anti-Ikaros antibody (other panels).
markers of RGCs (Brn3b), horizontal cells (Lim-1, calbindin), and amacrine cells (syntaxin, Pax6) ( Figures 6F-6N and not shown).
The number of cells expressing these markers was significantly reduced in adult ikaros À/À retinas compared to wild-types, suggesting that the decrease in early-born cell types is not compensated at later stages of retinal development in the ikaros À/À mouse. In contrast, the number of cone photoreceptors, another early-born cell type, was not changed, as judged by staining for cone opsin ( Figures 6O-6Q ). Importantly, the production of lateborn retinal cell types was not affected in the ikaros À/À retina, as we found no difference in the number of cells expressing markers of bipolar cells (CaB5 and PKC-alpha) and Mü ller cells (CyclinD3) ( Figure 6R -6W and not shown). These results indicate that inactivation of Ikaros leads to a specific and permanent decrease of early-born cell types in the mature retina, without affecting the number of late-born retinal cell types produced. As the ikaros À/À mouse is a germline knockout, we wondered whether the decrease in early-born retinal cell type could be due to nonspecific effects of Ikaros inactivation in non retinal tissues.
To inactivate Ikaros in a cell-and tissue-specific manner, we took advantage of an Ikaros dominant-negative isoform (IK-DN), which was previously shown to efficiently block Ikaros function in the hematopoietic system (Galy et al., 2000) . A bicistronic retroviral vector expressing IK-DN and GFP was used to infect RPCs at different stages of development. If the decrease of early-born cell types observed in the ikaros À/À retina were specifically due to Ikaros inactivation in RPCs, we expected that overexpression of IK-DN from an early stage would reproduce the ikaros À/À retina phenotype. In addition, if Ikaros function were required only in immature RPCs to confer early temporal competence, overexpression of Ikaros-DN in postnatal RPCs, which do not normally express Ikaros, should have no effect. As expected, overexpression of Ikaros-DN in E13 RPCs significantly reduced the proportion of clones containing early-born cell types such as amacrines (control, 10.5% ± 1.5%, n = 346 clones from 3 experiments; IK-DN, 3.0% ± 1.7%, n = 293 clones from 3 experiments) and for Prox-1), but no change in Crx expression was detected (P-R; n = 4 for WT and n = 3 for ikaros À/À ; p = 0.92). Sections in (A), (B), (D), (E), (J), (K), (P), and (Q) were counterstained with Hoechst to reveal cell nuclei. All quantifications are expressed as mean ± SEM. horizontal cells (control, 4.5% ± 2.3%, n = 346 clones from 3 experiments; IK-DN, 0.4 ± 0.6%, n = 293 clones from 3 experiments), as observed in the ikaros À/À retina. Unfortunately, because RGCs degenerate rapidly after they are generated in retinal explants, it was not possible to determine whether IK-DN overexpression also decrease RGC production. Importantly, overexpression of IK-DN in P0 RPCs had no effect on the generation of early or late-born retinal cell types (not shown). These results support our in vivo analysis of the ikaros À/À retina and strongly suggest that the reduction of early-born cell types in the ikaros À/À retina is due to inactivation of Ikaros in RPCs. In addition, these results provide further support to our model that Ikaros positivity in RPCs confer early temporal competence, whereas at later stages of development Ikaros function in RPCs is no longer required.
Misexpression of Ikaros in Late RPCs Induces Early-Born Cell Type Production
To determine whether Ikaros expression is sufficient to confer early temporal competence, we forced Ikaros expression in late RPCs, which do not normally express Ikaros, and asked whether these cells could generate early-born cell types. To do this, we used a replication-incompetent retroviral vector encoding Ikaros, together with placental alkaline phosphatase (AP) ( Figure S2 ). We injected this vector, or a control vector expressing AP only, into the subretinal space of P1 mice, and 20 days later, we analyzed the clones generated. The different cell types were identified based on their morphology, position of their cell body within the retinal layers, and expression of cell-typespecific markers ( Figure S2 ). Observation of Ikaros-expressing clones revealed dramatic changes in clonal composition. Very few photoreceptors were found in the Ikaros-expressing clones (7% compared to 71% in controls). As postmitotic photoreceptors do not normally express Ikaros (see Figure 3) , and because the reduction in photoreceptors did not appear to be accompanied by a compensatory increase in absolute number of other cell types, this result suggested to us that continued Ikaros expression in postmitotic photoreceptors might trigger apoptosis specifically in these cells. To test this possibility, we prepared retinal explants from P1 mice and infected them with the retroviral vector expressing Ikaros or a control retroviral vector. We then fixed the explants at different times after infection and counted the proportion of photoreceptor cells generated. Although the proportion of photoreceptors produced after misexpression of Ikaros was indistinguishable from that of controls 4 days after infection, the proportion of photoreceptors in Ikaros-infected explants rapidly decreased in the following days, suggesting that they were undergoing cell death ( Figure S3A -S3I). Staining for activated caspase-3 and TUNEL confirmed that many photoreceptor cells overexpressing Ikaros were undergoing apoptosis, whereas other cell types were not affected ( Figures S3J-S3O ). In control-infected explants, caspase-3 and TUNEL-positive photoreceptor cells were not found. These results indicate that Ikaros misexpression does not affect the survival of RPCs and the initial generation of photoreceptors, but it eventually leads to photoreceptor cell death a few days after they become postmitotic. Because photoreceptors are the most abundant cell type in the retina, and the majority of the clones contain only photoreceptor cells, we excluded photoreceptors from our quantifications in the following in vivo clonal analysis to avoid a misrepresentation in the proportions of nonphotoreceptor cell types due to the specific photoreceptor cell death in the Ikaros misexpressing clones. As expected, control clones generated in vivo contained only the three major cell types generated after birth: rod photoreceptors, bipolar cells, and Mü ller cells, as well as a small proportion of amacrine cells that is generated postnatally ( Figure 7A ). In contrast, analysis of the clones misexpressing Ikaros revealed that 16.6% ± 3.3% of the clones contained at least one horizontal cell, whereas clones containing horizontal cells were never observed in controls. In addition, the proportion of clones containing at least one amacrine cell was dramatically increased in Ikaros-expressing clones compared to controls (33.7% ± 1.8% versus 2.1% ± 0.8%). Remarkably, some two-cell clones contained a bipolar cell together with a horizontal cell after Ikaros misexpression ( Figure 7B ), which was never observed in controls. As horizontal cells are normally generated between E12 and E16 and bipolar cells are mostly generated between P0 and P5, these results suggest that the postnatal RPC that generated such clones had the competence to generate both early-and late-born cell types. In addition, several Ikarosexpressing clones contained more than two amacrine cells, whereas clones containing multiple amacrine cells were rarely observed in controls ( Figure 7C ). The amacrine cells and horizontal cells produced following Ikaros misexpression expressed the amacrine and horizontal cell markers Syntaxin and Lim-1 ( Figures 7D-7I ), indicating that they differentiated normally. Consistent with their expression of specific markers, amacrine and horizontal cells produced in postnatal retina following Ikaros misexpression adopted their typical morphology and were positioned normally within the retinal layers ( Figures 7B and 7C) . It remains unknown, however, whether these late-produced earlyborn cells are functional and can establish connections normally with their postsynaptic partners. Quantification of the proportion of the different cell types generated in the clones revealed that the increase in the generation of early-born amacrine and horizontal cells following Ikaros misexpression was accompanied by a slight decrease in bipolar cells and a complete block in Mü ller cells produced ( Figure 7J ). This increase of early-born cells could be caused by Ikaros triggering cell death of late-born bipolar and Mü ller cell. However, two different lines of evidence argue against this possibility. First, in our time course analysis of cell death in retinal explants, we did not observe Mü ller and bipolar cell death following Ikaros misexpression ( Figure S3) . Second, the size of the clones produced by RPCs misexpressing Ikaros was not significantly different from that of control clones ( Figure 7K ). Thus, ectopic expression of Ikaros in late RPCs does not trigger death of bipolar and Mü ller cells but is sufficient to confer the competence to late RPCs to generate early-born cell types, without resetting their proliferation capacity to that of an early embryonic RPC. In addition, these results indicate that downregulation of Ikaros expression in RPCs is required for the progression to the temporal competence stage in which RPCs generate Mü ller cells. Another cell type generated during early stages of retinal development is the RGC. However, we did not observe any RGC production following Ikaros misexpression in P1 RPCs in vivo. At least two different possibilities could explain this result. First, Ikaros expression alone may not be sufficient to induce RGC production. Second, negative feedback signals, which are known to prevent the production of RGCs at late stages of retinogenesis in vivo (Waid and McLoon, 1998; Wang et al., 2005) , could override Ikaros expression in late RPCs and prevent RGC production. To test this latter possibility, we removed late RPCs from the influence of negative feedback signals operating in vivo by placing them in dissociated low-density cultures. After plating, the RPCs were infected with a retroviral vector expressing Ikaros and GFP as a reporter or with a control retroviral vector expressing only GFP. Four days later, the cells were fixed and stained for Brn3b, a specific marker of RGCs. In this assay, a GFP-positive cell indicates that it was generated in culture since retroviral vectors infect only dividing cells. Among the total Brn3b-positive cells in the control culture, we did not find any that were GFP positive, confirming that RGCs are not generated from late RPCs. Remarkably, however, more than 12% of the Brn-3b-positive cells in the Ikaros-infected cultures were also GFP-positive ( Figures 7L-7N ), indicating that Ikaros misexpression in late RPCs is sufficient to confer the competence to generate RGCs, at least in culture. Together with our in vivo misexpression studies, the results of these misexpression experiments are consistent with a model in which Ikaros is sufficient to confer early temporal competence, without completely removing the late temporal competence status to postnatal RPCs ( Figure 7O ).
We next asked whether the downregulation of Ikaros observed in late RPC was required for the generation of late-born cell types. If this was the case, maintaining Ikaros expression throughout retinal development should prevent the generation of the laterborn cell types such as bipolar cells and Mü ller cells. To test this possibility, we infected RPCs at E13 with a retroviral vector expressing Ikaros together with GFP, and analyzed the clones generated 17 days later. Interestingly, we found that Ikaros overexpression in E13 RPCs did not affect the production of clones containing bipolar cells (control, 39.9% ± 4.0%, n = 404 clones; Ikaros, 36.7% ± 1.1%, n = 489 clones), whereas it decreased the production of clones containing Mü ller cells (control, 14.6% ± 3.1%, n = 404 clones; Ikaros, 3.3% ± 0.5%, n = 489 clones). Together with our finding that Ikaros misexpression in P1 RPCs does not affect bipolar cell production significantly but totally block Mü ller cell production, these results indicate that the downregulation of Ikaros expression in late RPCs is not necessary for progression to the temporal competence stage in which RPC can generate bipolar cells, whereas it is required for the progression to the temporal competence stage in which they can generate Mü ller cells.
Ikaros Acts as a Positive Regulator of Gene Expression in RPCs
We next sought to determine how Ikaros might induce early-born cell type production when misexpressed in late RPCs. One possibility was that it could function as a positive transcriptional regulator of genes required for early-born cell-type specification.
To test this hypothesis, we used a bicistronic retroviral vector to express Ikaros together with GFP in P0 RPCs. After 48 hr, we purified the GFP-positive cells by FACS, extracted mRNA, and performed semiquantitative RT-PCR. Interestingly, we found that the expression of Prox-1, a homeodomain protein expressed in dividing RPCs that is both necessary and sufficient for horizontal cell specification (Dyer et al., 2003) , was drastically increased following Ikaros misexpression in late RPCs. In contrast, the expression of Math5 and Islet-1, which are not expressed in proliferating RPCs but operate in postmitotic cells to promote the ganglion cell fate, did not change 48 hr after Ikaros misexpression. These results indicate that Ikaros functions to promote the expression of Prox-1 in postnatal RPCs, thereby conferring competence to these cells to acquire the horizontal cell fate. This result suggests that Ikaros might function as a specific inducer of genes involved in early-born cell type specification.
DISCUSSION
We report here that Ikaros confers early temporal competence to RPCs. We find that, during retinal development, Ikaros is expressed in early but not late RPCs. Misexpression of Ikaros in late RPCs is sufficient to confer competence to the cells to generate early-born retinal cell types, including RGCs, horizontal cells, and amacrine cells. In addition, we find that Ikaros mutant retinas have a reduced number of early-born cell types, whereas late-born cell types are unaffected. Together, these results suggest a model in which Ikaros expression confers early temporal competence to RPCs such that they can generate early-born retinal cell types. We discuss this model and its implications below.
Ikaros as a Regulator of Early Temporal Competence
The present findings support the hypothesis that Ikaros functions to confer early temporal competence to RPCs, rather than to instruct specific cell-fate decisions. Cell-fate determinants, such as bHLH transcription factors, generally act instructively to promote a particular cell fate. In contrast, Ikaros misexpression in late RPCs does not promote the production of one specific cell type but instead causes a general increase in the production of early-born cell types. Ikaros could still be a cellfate determinant factor that acts instructively to specify three different fates that just happen to be early-born cell types. Our results, however, do not appear to be consistent with this possibility. Misexpression of Ikaros in late RPCs does not completely prevent the generation of late-born cell types, and some 2-cell clones can even contain an early-born cell type, together with a late-born cell type, indicating that the RPC that gave rise to this type of clone was competent to produce both early and late-born cell types at the same time. This type of clone is most likely due to late RPCs expressing the normal late temporal competence factor(s) that allow production of late-born cell types, but the reintroduction of Ikaros adds another set of possible fates to these cells by conferring early temporal competence, thereby producing an RPC that can generate both early-and late-born cell types. These results indicate that Ikaros increases, but does not reset, the developmental potential of late RPCs, supporting a model in which the presence of Ikaros is not instructive but is instead permissive for the production of early-born cell types.
The mode of action of Ikaros appears to be unique compared to other previously identified so-called competence factors. For example, the bHLH transcription factor Math5 is thought to determine the competence state of retinal ganglion cell precursors (Brown et al., 1998; Mu et al., 2005a; Yang et al., 2003) . In contrast to Ikaros, Math5 is not expressed in RPCs, but acts in postmitotic RGC precursors to activate the expression of transcription factors involved in RGC differentiation (Yang et al., 2003) . In addition, Math5 expression alone is not sufficient to induce RGC generation from late RPCs, and Math5-expressing cells have been shown to give rise to other cell types that are generated at both early (amacrine and horizontal cells) and late (photoreceptor cells) stages of retinogenesis (Yang et al., 2003) . As we find that Math5 expression is significantly reduced in ikaros À/À retinas, our results suggest that Ikaros might act upstream of Math5. Recently, SOX2 was proposed to act as a regulator of RPC competence (Taranova et al., 2006) . In contrast to Ikaros, however, SOX2 appears to regulate the general competence of RPC to proliferate and differentiate rather than to control temporal competence to generate a class of cell types produced at a specific time in development. Another recently identified competence factor is GDF11, a member of the TGF-b family of signaling molecules. Unlike Ikaros, GDF11 is a secreted protein and apparently acts by regulating the time window that RPCs express certain transcription factors involved in RGC genesis such as Math5, without affecting RPC proliferation (Kim et al., 2005) . Thus, GDF11 is a negative feedback signal that prevents prolonged RGC production, whereas Ikaros is a positive, cell-intrinsic regulator of early temporal competence in RPCs. But could GDF11 control the timing of Ikaros expression? This possibility appears unlikely as the number of horizontal cells is unchanged in the gdf11 mutant mice (Kim et al., 2005) , whereas horizontal cells are reduced in ikaros mutant mice (this study). It remains possible, however, that GDF11 acts in concert with another factor to regulate Ikaros expression. Consistent with Ikaros regulating early temporal competence, we find that the number of Ikaros-positive RPCs gradually decreases over time during retinal development. By P2, less than 1% of RPCs express Ikaros, whereas at P4 no RPCs express Ikaros. Because a few amacrine cells are still generated at P2, we propose that the rare RPCs expressing Ikaros in the postnatal retina are those that are still competent to give rise to amacrine cells. Interestingly, we find that Ikaros-positive RPCs actually give rise to Ikaros-negative RPCs at later stages in the same lineage. These results indicate that, much like Hunchback in Drosophila neuroblast lineage, Ikaros expression constitutes a temporal stage of all RPCs, rather than a separate pool of cells that expand specifically during early stages of retinogenesis. Although Ikaros apparently confers the competence to generate early-born cell types, one exception appears to be the cone photoreceptors. In the mature retina, Ikaros is not expressed in rod or cone photoreceptor cells, and we find that the number of cone photoreceptor cells is not affected in the ikaros À/À retinas. This suggests that the mechanisms regulating temporal competence to generate cone photoreceptors do not depend on Ikaros.
Perhaps one of the most interesting findings in this study is that misexpression of Ikaros alone in late RPCs is sufficient to confer competence to generate early-born neurons. This result is strikingly similar to experiments in Drosophila in which Hunchback was reintroduced in older neuroblasts, which then resumed the generation of early-born GMCs (Pearson and Doe, 2003 ). Another similarity between our Ikaros misexpression results in late RPCs and the misexpression experiments of Hunchback in Drosophila neuroblasts is that temporal competence appears to be independent of proliferation capacity (Pearson and Doe, 2003) . In both cases, misexpression of Ikaros or Hunchback increased early-born cell type production at the expense of late-born cell types, without increasing clone size significantly. Despite these similarities with Hunchback misexpression experiments, there are some differences. In Drosophila, young neuroblasts that are forced to continually express Hunchback generate exclusively early-born GMCs (Isshiki et al., 2001) . In contrast, early E13 RPCs that are forced to continually express Ikaros give rise to more early-born neurons (not shown) but can still progress to generate some late-born neurons such as bipolar cells. These results suggest that downregulation of Ikaros expression is not required for RPCs to progress to a late temporal competence stage in which they can generate bipolar cells. An attractive possibility to explain this result is that the expression of a late temporal competence regulator is required for production of late-born neurons, and this factor can function even in the presence of Ikaros. Interestingly, however, continuous expression of Ikaros from E13 RPCs or misexpression of Ikaros in P1 RPCs either dramatically reduces, or completely abolishes, Mü ller cell production. These results are very similar to Hunchback overexpression experiments in flies and suggest that downregulation of Ikaros is required for RPCs to progress to the competence stage in which they can generate Mü ller cells. Thus, although downregulation of Ikaros is not required for production of all late-born retinal cell types, its downregulation appears to be a requirement for RPCs to progress to the last temporal competence stage in which they can generate Mü ller cells.
Mechanism of Ikaros-Mediated Regulation of Early Temporal Competence
The mechanism by which Ikaros regulates temporal competence in RPCs remains unclear. During hematopoiesis, Ikaros is thought to act as a transcriptional repressor by associating with the histone deacetylase (HDAC)-containing complexes such as NuRD and Sin3 . However, Ikaros can also function as a potentiator of gene expression in T cell development, apparently by recruiting Swi/Snf chromatin-remodeling complexes to specific cell-fate-decision genes (Harker et al., 2002; Koipally et al., 2002) . A recent study has shown that a switch in subunit composition of neural SWI/SNF-like chromatin remodeling complexes accompanies the developmental transition from neural stem cells to committed neuronal lineages (Lessard et al., 2007) . It will be interesting to determine whether Ikaros might be involved in this switch. Based on these previous studies, it is tempting to speculate that Ikaros might function to regulate chromatin conformation around genes involved in cellfate specification and differentiation in the retina. Interestingly, a recent bioinformatics study identified a potential functional role for an Ikaros motif in retina-specific genes (Nelander et al., 2005) , and future experiments should help determine whether these genes are under the control of Ikaros in RPCs and in differentiated retinal cell types. If Ikaros acts as a regulator of gene expression in RPCs, it could either repress the expression of genes required for late-born cell type production or promote the expression of genes required for early-born cell type production. Our results are consistent with the latter possibility. Indeed, we found that Ikaros misexpression in late RPCs increases expression of Prox-1, a homeodomain transcription factor that is necessary and sufficient for horizontal cell specification (Dyer et al., 2003) . Our finding that Ikaros misexpression does not affect Math5 and Islet-1 expression is not surprising, as these genes are thought to function in postmitotic cells, whereas Ikaros apparently functions in dividing RPCs to confer early temporal competence. The induction of Prox-1 expression by Ikaros is consistent with this idea, as Prox-1 is expressed and functions in dividing RPCs to control horizontal cell genesis (Dyer et al., 2003) . It will be interesting to determine whether other genes are induced by Ikaros misexpression in late RPCs, as they would constitute prime candidates to instruct dividing RPCs to take on early-born cell fates.
Our finding that the number of proliferating cells is reduced transiently at E13 in ikaros À/À retinas suggests that RPCs either slow down or stop their cell cycle during the period when Ikaros is required to specify temporal competence, but then resume normal proliferation once the RPCs no longer require Ikaros. This is an interesting observation as it suggests that temporal competence is specified independently of cell-cycle progression, since the progression to late temporal competence stage still occurs normally in the ikaros À/À retinas, despite reduced proliferation in early RPCs. Drosophila neuroblasts can also apparently specify temporal identity independently of cell-cycle progression. In the neuroblast lineage, although the Hunchback-to-Krü ppel transition requires cytokinesis, the Krü ppelto-Pdm1-to-Castor transitions occur normally in G2-arrested neuroblasts (Grosskortenhaus et al., 2005) . A similar cell-cycle independent differentiation timing mechanism has been proposed for the oligodendrocyte lineage (Durand and Raff, 2000) , which differentiate faster, after fewer divisions, when their cell cycle is slowed down by cooling to 33 C (Gao and Raff, 1997 ). It will be interesting to directly determine whether the transition from Ikaros-positive to Ikaros-negative RPCs is dependent on cell-cycle progression.
Because other Ikaros family members are also expressed in the developing retina ( Figure S4 ), we cannot exclude the possibility that other members act together with Ikaros to regulate temporal competence. Because mouse knockouts of eos and pegasus have not yet been generated, it remains unknown whether these genes can compensate for Ikaros loss of function. As early-born cell types are not completely missing in the ikaros À/À retina, it appears that this is a likely possibility. Alternatively, Ikaros might function together with another yet unidentified factor that can partially compensate for Ikaros inactivation. Some combinatorial code of Ikaros family member expression in subtypes of RPCs might also function to regulate temporal competence more precisely. At this time, however, it remains unknown whether a particular RPC can express different combination of Ikaros family members. The generation of specific antibodies should help resolve this issue.
A Model of Temporal Competence in the Developing
Retina Are all RPCs born equal and then ''learn'' their temporal competence from their environment, or are they intrinsically preprogrammed to change their competence to generate particular cell types over time? Several lines of evidence now support the latter possibility. First, RPCs are heterogeneous and do not necessarily have the same temporal competence at any specific time. For example, at mid to late embryonic stages, some RPCs are still competent to generate early-born cell types, whereas others have lost this competence and acquired the competence to generate late-born retinal cell types. Based on these observations, it is difficult to imagine how a single environmental signal could provide the temporal cues for a population of heterogeneous RPCs. Our finding that Ikaros is expressed in only a sub-population of RPCs at mid stages of retinogenesis suggests a potential molecular explanation for this heterogeneous temporal competence of RPCs. Second, even when isolated in clonal-density cultures, RPCs can give rise to clones that contain the same number of cells and the same proportion of cell types as clones that develop in vivo (Cayouette et al., 2003) . As the in vitro and in vivo environments are very different, this suggests an important role for intrinsic developmental programs in the regulation of temporal competence. Third, there is now evidence for reproducible lineages giving rise to specific combinations of cell types in the vertebrate retina (Cayouette et al., 2006; Poggi et al., 2005) , suggesting that lineage-dependent fate decisions contribute to changes in temporal competence. Together, these observations suggest that cell-intrinsic mechanisms act in RPCs to control temporal competence, and our data indicate that Ikaros is one of these potential intrinsic regulators. Based on our results, we propose the following model (Figure 8) . In large multipotent lineages, Ikaros-positive RPCs constitute the beginning of the lineage and give rise to Ikaros-negative RPCs at the end of the lineage. Expression of Ikaros in early RPCs confers the competence to generate early-born cell types by inducing expression of genes involved in early-born cell fate specification, whereas Ikaros-negative RPCs loose this early temporal competence.
In conclusion, our findings point to Ikaros as a key regulator of early temporal competence, suggesting a general strategy for the regulation of chronological order of cell birth from Drosophila to mammals. Our results also have potential implications for cell replacement therapies, as we have shown that re-expression of a single gene into late, lineage-restricted RPCs, can turn them back into RPCs with the differentiation potential of early multipotent RPCs, without resetting their proliferation potential. This suggests that, in theory, lineage-restricted neural progenitors could be manipulated to behave more like ''stem cells'' as far as their differentiation potential is concerned, but without the inconvenience of indefinite cell proliferation, which can lead to tumor formation.
EXPERIMENTAL PROCEDURES Animals
All animal work was carried in accordance to the Canadian Council on Animal Care guidelines. CD1 and Ik Null (Wang et al., 1996) on C57/B6 backgrounds, and Sprague Dawley rats were used in this study.
Retroviral Vector Constructions and Production
The retroviral vectors expressing Ikaros and a reporter gene were constructed by cloning the Ikaros full-length cDNA into the pCLE (Gaiano et al., 1999) or LZRS (Christopherson et al., 2001 ) retroviral vectors. The retroviral vectors were prepared and purified as previously described (Cayouette et al., 2003) .
Subretinal Injections and Clonal Analysis
Mice were injected subretinally at P1 with 1ml of pCLE-AP, encoding human placental alkaline phosphatase (Gaiano et al., 1999) or with LZRS-EGFP (Christopherson et al., 2001 ) into one eye, and the other eye was injected with a retroviral vector encoding Ikaros and the reporter genes EGFP or AP. The eyes were collected at P21. For the detection of alkaline phosphatase activity, retinal sections were first fixed in paraformaldehyde 4% for 1 hr and then immersed in PBS at 65 C for 1 hr. The eyes were then immersed in a solution of 4-nitro blue tetrazolium chloride (NBT/BCIP, Roche) or with Sigma Fast Red (Sigma) at 37 C until desired level of staining was achieved.
Retinal Explants and Dissociated Retinal Cell Culture
For in vitro experiments, retinal explants and dissociated cell cultures were prepared as previously described (Cayouette et al., 2001) . For dissociated cell cultures, 150,000 cells were plated and cultured on poly-lysine and laminin-coated glass coverslips for 3-4 days.
Probes and In Situ Hybridization
Digoxigenin-labeled RNA probes were synthesized from complete cDNA vectors pBluescript-Ikaros or pBluescript-Crx. Eyes were collected and frozen immediately in OCT, sectioned, air-dried for 30 min, and fixed in PFA 4% for 20 min. Sections were then digested with 2 mg/ml of proteinase K at room temperature for 20 min. Hybridization was done at 65 C overnight with 300 ng/ml of RNA probes in the hybridization buffer (50% formamide, 53 SSC, 53 Denhardt's, 5 mg/ml of Torula RNA, 500ug/ml fish sperm DNA). The probes were detected with an anti-Dig-AP antibody (1:3500, Roche). The AP activity was revealed using the 4-nitro blue tetrazolium chloride (NBT/BCIP, Roche).
Histology, Immunofluorescence, and TUNEL The eyes were fixed by immersion in 4% paraformaldehyde, cryoprotected in sucrose 20%, frozen, and embedded in a mix sucrose:OCT (1:1). Cryostat sections (12 um) were collected on Superfrost plus slides. For immunofluorescence, retinas were sectioned and processed for staining on the same day. Slides were preincubated 30 min in antibody buffer (NaCl 50 mM, Tris Base 50 mM, BSA 1%, L-Lysin 100 mM, Azide 0.04% [pH 7.4]) containing 0.4% Triton and 10% serum and then incubated overnight at 4 C with the primary antibodies (see Table S1 ) diluted in antibody buffer. For anti-Ikaros immunostaining, rat retinal sections were used to increase signal to noise ratio, which was lower on mouse tissue. The monoclonal anti-Ikaros antibody we used was previously reported to be specific for Ikaros and not recognize Aiolos and Helios . We independently tested that this antibody does not recognize overexpressed Eos and Pegasus in NIH 3T3 cells. Similar Ikaros immunostaining results were also obtained using a different polyclonal antibody against Ikaros (Hahm et al., 1994) . Bound antibodies were detected with using appropriate secondary antibodies conjugated with Alexa 488 or 555 (1:1000; Molecular Probes) diluted in antibody buffer at room temperature for 1 hr. For Brn3b detection, sections were incubated in 0.3% peroxide in PBS for 1 hr at room temperature, then incubated with a Donkey anti-Goat biotinylated secondary antibody (1:400; Jackson Immunoresearch) diluted in TSA blocking buffer (1%; Molecular Probes) followed by an incubation with Avidin Biotin Complex (ABC elite; Vector laboratories) for 30 min. HRP was revealed using a Tyramide signal amplification kit (Molecular Probes). To detect apoptotic cells, retinal sections were processed for Terminal dUTP-Nick End Labeling (TUNEL), using Apoptag Plus kit (Chemicon) according to the recommendations of the manufacturer.
Quantitative Analysis
The number of cells expressing the different cell-type-specific markers was quantified by averaging the total number of positive cells on three different retinal sections at E13 and E16, centered on the optic nerve head. The proportions obtained were always adjusted relative to wild-type littermates' values to avoid small differences in developmental stages from one litter to another. In the adult retina, the average number of positive cells from three regions of 100-250 mm in the midperipheral retina at the level of the optic nerve taken from both retinal hemispheres was counted for each animal. For in situ, pixel intensity from three different sections per animal was quantified using Matlab. Statistical comparisons were done using Student's t test.
RT-PCR For RT-PCR on FACS-sorted cells, poly(A)
+ mRNA was prepared using a QuickPrep Micro mRNA Purification kit (GE Healthcare), and cDNA synthesis was carried out using a SMART PCR cDNA Synthesis kit (Clontech Laboratories), each according to the suppliers' instructions. The PCR-amplified total cDNA was used as the template for the RT-PCR reaction. Before performing the PCR reaction, the amplified cDNA samples were all electrophoresed on the same 1% agarose gel, stained with ethidium bromide (EtBr, 0.4 mg/ml), and normalized according to the intensity of staining. All primers were dissolved in water. The RT-PCR reactions were carried out in 25 ml of reaction mixture containing 200 pg of PCR-amplified total cDNA as template, 200 nM 5 0 PCR primer and 200 nM 3 0 PCR primer, 0.2 mM dNTP, 1.5 mM MgCl 2 , 13 PCR buffer (pH 8.7), 13 Q solution, and 0.25 units of TopTaq DNA polymerase (QIAGEN). The reaction mixture was denatured for 1 min at 94 C. The PCR reaction was then started, using 94 C for 30 s for the denaturing step at 60 C for Isl1, Math5, Prox-1, GAPDH, for 30 s for the annealing step, and 72 C for 1 min for the elongation step. All PCR reactions generated a single band of the expected size. Primers are shown in Table S2 . 
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